Effects of Alcohol Septal Ablation on Exercise Hemodynamics, Symptoms, and Quality of Life in Obstructive Hypertrophic Cardiomyopathy
ASA significantly reduced exercise-induced filling pressures and LVOT obstruction, leading to improved symptoms and quality of life in patients with obstructive hypertrophic cardiomyopathy.
Authors
- Morten K. Jensen (ORCID: https://orcid.org/0000-0003-1144-4603)
- Christian Juhl Terkelsen (ORCID: https://orcid.org/0000-0003-0205-9551)
- Mads J. Andersen (ORCID: https://orcid.org/0000-0002-9320-8227)
- Steen Hvitfeldt Poulsen (ORCID: https://orcid.org/0000-0002-9586-835X)
- Anne M. Dybro (ORCID: https://orcid.org/0000-0003-3175-9725)
- Bertil Ladefoged (ORCID: https://orcid.org/0000-0002-3749-6789)
- Anders Lehmann Dahl Pedersen (ORCID: https://orcid.org/0000-0002-3258-5192)
- Roni Nielsen (ORCID: https://orcid.org/0000-0001-9228-3869)
- Torsten B. Rasmussen (ORCID: https://orcid.org/0000-0003-1468-7248)
Institutions
- Aarhus University (DK)
- Aarhus University Hospital (DK)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-08-19
- DOI
- https://doi.org/10.1161/jaha.125.041328
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Alnylam Pharmaceuticals
- Cytokinetics
- Novo Nordisk